CVKD
NASDAQ · Pharmaceuticals

Cadrenal Therapeutics Inc

$6.35
-0.32 (-4.80%)
As of May 9, 2:22 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +166.9% upside
Low Target $12.65
Average Target $16.95
High Target $22.59
Current Price $6.35
Current
$6.35
Target
$16.95
$12.65 $16.95 avg $22.59
Scenario Analysis
Bear Case
$12.65
99.2%
Low target
Base Case
$16.95
+166.9%
Avg target
Bull Case
$22.59
+255.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$16.50
-61.5% from high
52-Week Low
$4.21
+50.8% from low
Target vs 52W High
$16.95
+2.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%